PulseAugur
中
实时 11:13:56
实体 Drug Therapies and the Risk of Malignancy in Crohn's Disease: Results From the TREAT™ Registry

Drug Therapies and the Risk of Malignancy in Crohn's Disease: Results From the TREAT™ Registry

PulseAugur coverage of Drug Therapies and the Risk of Malignancy in Crohn's Disease: Results From the TREAT™ Registry — every cluster mentioning Drug Therapies and the Risk of Malignancy in Crohn's Disease: Results From the TREAT™ Registry across labs, papers, and developer communities, ranked by signal.

Show in brief
总计 · 30天
1
90 天内 1
发布 · 30天
0
90 天内 0
论文 · 30天
0
90 天内 0
层级分布 · 90 天
主题
情绪 · 30 天

1 天有情绪数据

最近 · 第 1/1 页 · 共 1 条
  1. TOOL · CL_368617 ·

    Isomorphic Labs 和 MSD 合作,推动人工智能驱动的癌症药物发现

    Isomorphic Labs 和 MSD 已建立合作伙伴关系,专注于利用人工智能进行癌症药物发现。他们的合作旨在开发靶向小分子的新型肿瘤药物疗法。